As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
Cell Notes: Looking Back, Moving Forward: Exciting New Developments in Biotherapies
December 18, 2024
FDA Workshop to Focus on Generating Scientific Evidence to Facilitate CT Development
December 18, 2024
Advanced Therapies Week: AABB to Host Fireside Chat on Sustainable Donor Sourcing
December 13, 2024